A case study from St Thomas’ Hospital in speeding up Candida auris detection and isolation

Craig Ryan, Molecular Product Manager at Randox Laboratories Ltd., hosts a discussion with Désirée Prossomariti, Guy’s and St Thomas’ NHS Foundation Trust, on the transformative impact of switching from culture-based testing to PCR for managing Candida auris. The conversation highlights the limitations of traditional methods, the outbreak that prompted change, and the successful implementation of Vivalytic cartridge-based PCR assays, which drastically reduced turnaround times from over 90 hours to just 26. This shift enabled faster patient isolation, reduced strain on biomedical scientists, and improved overall outbreak control. Prossomariti also shares operational insights and encourages other hospitals to consider PCR adoption for better patient management.